Saudi Pharmaceutical Industries and Medical Appliances Corporation SJSC banner

Saudi Pharmaceutical Industries and Medical Appliances Corporation SJSC
SAU:2070

Watchlist Manager
Saudi Pharmaceutical Industries and Medical Appliances Corporation SJSC Logo
Saudi Pharmaceutical Industries and Medical Appliances Corporation SJSC
SAU:2070
Watchlist
Price: 27.9 SAR 2.57%
Market Cap: ﷼3.3B

EV/S

2.6
Current
5%
Cheaper
vs 3-y average of 2.7

Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.

EV/S
2.6
=
Enterprise Value
﷼4.4B
/
Revenue
﷼1.7B

Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.

EV/S
2.6
=
Enterprise Value
﷼4.4B
/
Revenue
﷼1.7B

Valuation Scenarios

Saudi Pharmaceutical Industries and Medical Appliances Corporation SJSC is trading below its 3-year average

If EV/S returns to its 3-Year Average (2.7), the stock would be worth ﷼29.41 (5% upside from current price).

Statistics
Positive Scenarios
4/4
Maximum Downside
No Downside Scenarios
Maximum Upside
+109%
Average Upside
36%
Scenario EV/S Value Implied Price Upside/Downside
Current Multiple 2.6 ﷼27.9
0%
3-Year Average 2.7 ﷼29.41
+5%
5-Year Average 2.8 ﷼30.9
+11%
Industry Average 5.4 ﷼58.35
+109%
Country Average 3.1 ﷼33.25
+19%

Forward EV/S
Today’s price vs future revenue

Today's Enterprise Value Revenue Forward EV/S
﷼4.4B
/
Jan 2026
﷼1.7B
=
2.6
Current
﷼4.4B
/
Dec 2026
﷼2B
=
2.2
Forward
﷼4.4B
/
Dec 2027
﷼2.2B
=
2
Forward
﷼4.4B
/
Dec 2028
﷼2.4B
=
1.8
Forward

Forward EV/S shows whether today’s EV/S still looks high or low once future revenue are taken into account.

Peer Comparison

All Multiples
EV/S
P/E
All Countries
Close
Market Cap EV/S P/E
SA
Saudi Pharmaceutical Industries and Medical Appliances Corporation SJSC
SAU:2070
3.3B SAR 2.6 18.1
US
Eli Lilly and Co
NYSE:LLY
825.8B USD 13.2 40
US
Johnson & Johnson
NYSE:JNJ
548.5B USD 6 26.1
CH
Roche Holding AG
SIX:ROG
248.4B CHF 4.7 20.1
UK
AstraZeneca PLC
LSE:AZN
215.6B GBP 5.1 27.5
CH
Novartis AG
SIX:NOVN
220.1B CHF 5.2 19.8
US
Merck & Co Inc
NYSE:MRK
272.3B USD 4.7 14.9
IE
Endo International PLC
LSE:0Y5F
244.4B USD 108.7 -83.6
DK
Novo Nordisk A/S
CSE:NOVO B
1.2T DKK 4.1 11.4
US
Pfizer Inc
NYSE:PFE
150.6B USD 3.2 19.4
US
Bristol-Myers Squibb Co
NYSE:BMY
117.3B USD 3.1 16.6

Market Distribution

In line with most companies in Saudi Arabia
Percentile
43rd
Based on 256 companies
43rd percentile
2.6
Low
0.2 — 1.8
Typical Range
1.8 — 5.5
High
5.5 —
Distribution Statistics
Saudi Arabia
Min 0.2
30th Percentile 1.8
Median 3.1
70th Percentile 5.5
Max 1 289.3

Saudi Pharmaceutical Industries and Medical Appliances Corporation SJSC
Glance View

Market Cap
3.3B SAR
Industry
Pharmaceuticals

Saudi Pharmaceutical Industries & Medical Appliances Corp. engages in the development, manufacture and sale of pharmaceutical products and medical appliances. The company is headquartered in Riyadh, Riyadh. The firm is organized, together with its subsidiaries, into two business segments: the Medical and pharmaceutical production segment focuses on the manufacture, production, development and marketing of pharmaceutical raw materials and medical appliances, as well as the production of consumables medical appliances, and the Investment segment is engaged in investing activity in associates and investment in securities. The Company’s product pipeline includes tablets, capsules, dry powder for suspension, syrups and suspensions, injections, creams, ointments and gels, suppositories, mouthwash and antiseptic products. The Company’s manufacturing facility is located at Qassim Industrial City, about 320 kilometers north-west of Riyadh.

Intrinsic Value
27.46 SAR
Overvaluation 2%
Intrinsic Value
Price ﷼27.9
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett